ScholarIQanswers from OpenAlex
National Marrow Donor Program
InstitutionResearch output, impact & collaborations
National Marrow Donor Program is a institution indexed in ScholarIQ from OpenAlex.
What is known about National Marrow Donor Program?
ScholarIQrecord summary
National Marrow Donor Program is a research organisation in Minneapolis, US. OpenAlex records 2,217 works and 191,392 citations for it. 506 researchers list it as their most recent affiliation.
How many works does National Marrow Donor Program have?
ScholarIQindexed works
National Marrow Donor Program has 2,217 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does National Marrow Donor Program have?
ScholarIQcitation count
National Marrow Donor Program has 191,392 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at National Marrow Donor Program?
ScholarIQresearcher count
National Marrow Donor Program has 506 researchers in the ScholarIQ index.
What is the average h-index at National Marrow Donor Program?
ScholarIQavg h-index
National Marrow Donor Program has an average h-index of 72.5 in OpenAlex.
What is the ROR of National Marrow Donor Program?
ScholarIQror
The ROR for National Marrow Donor Program is on the source record.
What is the OpenAlex record for National Marrow Donor Program?
ScholarIQopenalex
The OpenAlex for National Marrow Donor Program is on the source record.
Who are the most-cited researchers behind National Marrow Donor Program?
ScholarIQtop researchers by citations
What are the most-cited papers on National Marrow Donor Program?
ScholarIQmost cited works
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D’Souza, Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra, Steven M. Devine, Mary Eapen, Mehdi Hamadani, Parameswaran Hari, Marcelo C. Pasquini, Waleska S. Pérez, Rachel Phelan, Marcie Riches, J. Douglas Rizzo, Wael Saber, Bronwen E. Shaw, Stephen R. Spellman, Patricia Steinert, Daniel J. Weisdorf, Mary M. Horowitz
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine
William Blum, Ramiro Garzon, Rebecca B. Klisovic, Sebastian Schwind, Alison Walker, Susan M. Geyer, Shujun Liu, Violaine Havelange, Heiko Becker, Larry J. Schaaf, Jon Mickle, Hollie Devine, Cheryl Kefauver, Steven M. Devine, Kenneth K. Chan, Nyla A. Heerema, Clara D. Bloomfield, Michael R. Grever, John C. Byrd, Miguel A. Villalona‐Calero, Carlo M. Croce, Guido Marcucci
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He, Daniel R. Couriel, Álvaro Urbano-Ispizúa, Corey Cutler, Andrea A. Bacigalupo, Minoo Battiwalla, Mary E.D. Flowers, Mark Juckett, Stephanie J. Lee, Alison W. Loren, Thomas R. Klumpp, Susan E. Prockup, Olle Ringdén, Bipin N. Savani, Gèrard Socié, Kirk R. Schultz, Thomas R. Spitzer, Takanori Teshima, Christopher Bredeson, David A. Jacobsohn, Robert J. Hayashi, William R. Drobyski, Haydar Frangoul, Görgün Akpek, Vincent T. Ho, Victor Lewis, Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, José Antonio Pérez‐Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand, Arnon Nagler, Edie Weller, Steven M. Devine, David Avigan, Yi‐Bin Chen, Mark Kaminski, H. Kent Holland, Jane N. Winter, James R. Mason, Joseph W. Fay, David A. Rizzieri, Chitra Hosing, Edward D. Ball, Joseph P. Uberti, Hillard M. Lazarus, Markus Y. Mapara, Stephanie A. Gregory, John M. Timmerman, David Andorsky, Reuven Or, Edmund K. Waller, Rinat Rotem‐Yehudar, Leo I. Gordon
Outcome of Transplantation for Myelofibrosis
Karen K. Ballen, Smriti Shrestha, Kathleen A. Sobocinski, Mei-Jie Zhang, Asad Bashey, Brian J. Bolwell, Francisco Cervantes, Steven M. Devine, Robert Peter Gale, Vikas Gupta, Theresa Hahn, William J. Hogan, Nicolaus Kröger, Mark R. Litzow, David I. Marks, Richard T. Maziarz, Philip L. McCarthy, Gary J. Schiller, Harry C. Schouten, Vivek Roy, Peter H. Wiernik, Mary M. Horowitz, Sergio Giralt, Mukta Arora
How much of the research on National Marrow Donor Program is open access?
ScholarIQopen access share
100%OPEN ACCESS